(Q53885278)
Statements
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. (English)
G Ritter
L J Old
A M Scott
F T Lee
W Hopkins
J S Cebon
J M Wheatley
Z Liu
F E Smyth
C Murone
S Sturrock
D MacGregor
N Hanai
K Inoue
M Yamasaki
M W Brechbiel
I D Davis
R Murphy
A Hannah
M Lim-Joon
T Chan
G Chong
E W Hoffman
A W Burgess
1 October 2001
19
19
3976-3987